Skip to main content

Table 2 EQ-5D-5L responses by stage of treatment

From: A life that’s worth living – measuring health-related quality of life among people treated for tuberculosis in Viet Nam: a longitudinal EQ-5D-5L survey

 

Intensive phase

Continuation phase

End of treatment

  

N

%

N

%

N

%

Δ¥

p-value

MOBILITY

        

No problems

407

69.6

442

75.6

494

84.4

+ 14.8

< 0.001

Any problems

178

30.4

143

24.5

91

15.6

-14.8

 

 Slight problems

132

22.6

103

17.6

54

9.2

-13.4

 

 Moderate problems

15

2.6

19

3.3

16

2.7

+ 0.1

 

 Severe problems

28

4.8

19

3.3

18

3.1

-1.7

 

 Unable to walk about

3

0.5

2

0.3

3

0.5

0.0

 

SELF-CARE

        

No problems

529

90.4

527

90.1

541

92.5

+ 2.1

0.361

Any problems

56

9.6

58

9.9

44

7.5

-2.1

 

 Slight problems

41

7.0

43

7.4

27

4.6

-2.4

 

 Moderate problems

5

0.9

7

1.2

6

1.0

+ 0.1

 

 Severe problems

7

1.2

3

0.5

7

1.2

0.0

 

 Unable to wash or dress myself

3

0.5

5

0.9

4

0.7

+ 0.2

 

USUAL ACTIVITIES

        

No problems

387

66.2

449

76.8

510

87.2

+ 21.0

< 0.001

Any problems

198

33.8

136

23.2

75

12.8

-21.0

 

 Slight problems

128

21.9

98

16.8

40

6.8

-15.1

 

 Moderate problems

22

3.8

13

2.2

12

2.1

-1.7

 

 Severe problems

26

4.4

14

2.4

15

2.6

-1.8

 

 Unable to do

22

3.8

11

1.9

8

1.4

-2.4

 

PAIN/DISCOMFORT

        

No pain

270

46.2

324

55.4

413

70.6

+ 24.4

< 0.001

Any pain

315

53.8

261

44.6

172

29.4

-24.4

 

 Slight pain

227

38.8

175

29.9

117

20.0

-18.8

 

 Moderate pain

43

7.4

45

7.7

21

3.6

-3.8

 

 Severe pain

42

7.2

36

6.2

32

5.5

-1.7

 

 Extreme pain

3

0.5

5

0.9

2

0.3

-0.2

 

ANXIETY/DEPRESSION

        

Not anxious or depressed

380

65.0

414

70.8

451

77.1

+ 12.1

< 0.001

Any anxiety or depression

205

35.0

171

29.2

134

22.9

-12.1

 

 Slightly

127

21.7

106

18.1

80

13.7

-8.0

 

 Moderately

34

5.8

33

5.6

26

4.4

-1.4

 

 Severely

42

7.2

27

4.6

22

3.8

-3.4

 

 Extremely

2

0.3

5

0.9

6

1.0

+ 0.7

 
  1. Notes: ¥ Frequency difference between the Intensive Phase and End of Treatment; ¶ Wilcoxon signed-rank test